# Arcutis Biotherapeutics, Inc.: Form SC 13D/A, filed Mar 6, 2024

- Company: [Arcutis Biotherapeutics, Inc.](/companies/arqt.md) (CIK 1787306)
- Form: SC 13D/A
- Filed: 2024-03-06
- Accepted by EDGAR: Mar 6, 2024, 12:40 ET
- Period: not reported
- Accession: 0001193125-24-060422
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1787306/000119312524060422/d643419dsc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1787306/000119312524060422/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1787306/000119312524060422/d643419dsc13da.htm

Filed Mar 6, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-060422. Last ingested by Listed: Nov 4, 2026, 20:19 ET. No prices; not investment advice.